SQZ Biotechnologies Co. (SQZ) Social Stream



SQZ Biotechnologies Co. (SQZ): $12.28

-0.98 (-7.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SQZ to Watchlist
Sign Up

Industry: Biotech


Ranked

of 476

in industry

SQZ Biotechnologies Co (SQZ) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SQZ.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $46 $29 $36.25 $14.37 152.26%

The Trend in the Analyst Price Target


Over the past 47 weeks, SQZ's average price target has gone down $2.08.

Over the past 47 weeks, SQZ's average upside potential has been 93.63%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-12 5 46 29 36.25 14.03 158.37%
2021-02-13 3 40 38 39.00 18.56 110.13%
2020-12-19 NA 40 37 38.33 24.74 54.93%

SQZ Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SQZ has a higher upside potential (average analyst target price relative to current price) than 89.48% of all US stocks.
  • The average analyst price target of SQZ is greater than 75.79% of stocks in the small market cap category.
  • SQZ has a less variance in analysts' estimates than 27.94% of stocks in the small market cap category.
  • SQZ Biotechnologies Co's number of analysts covering the stock is greater than 71.36% of stocks in the small market cap category.

In the Pharmaceutical Products industry, ACET, TARS and CMRX are the three stocks most similar to SQZ Biotechnologies Co regarding the price target and analyst recommendation information presented here.

Is SQZ a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7509 seconds.